Near-earth Satellites
Debate between Lord Lansley and Lord Evans of Rainow
Lord Evans of Rainow (Con)
The noble Lord never lets us down, does he? My understanding, in answer to the question, is that he resigned and was not sacked—but I was hoping that the noble Lord would ask about future investment in Scotland.
Lord Lansley (Con)
My Lords, my noble friend will be aware that from 1 January we are rejoining the Copernicus Programme. The Sentinel system for Copernicus of near-earth orbiting satellites provides us with absolutely vital data, not least in relation to climate change. How might the British space industry, as a world leader, benefit from our rejoining Copernicus in the next three years?
Lord Evans of Rainow (Con)
That is a very specific question about rejoining that organisation, and I do not have an answer to it for my noble friend, but I shall certainly write on that specific point.
Community Pharmacies
Debate between Lord Lansley and Lord Evans of Rainow
Lord Lansley (Con)
My Lords, we can anticipate that our Prime Minister understands something about pharmacy for obvious reasons. In my experience over some years, the opportunity lies in the hands of local NHS commissioners. The contract allows them to commission additional services such as minor illness services and, in the past, medicine use reviews, but they often did not do so. What steps might the Government now take with ICBs to encourage them to undertake more of the commissioning of additional services?
Lord Evans of Rainow (Con)
I thank my noble friend for that very good question. ICBs are encouraged to do exactly what he says. I refer to an answer I gave earlier: from summer 2023, NHS England will start piloting prescribing services in community pharmacies—exactly as he suggests.
Medical Devices and Equipment
Debate between Lord Lansley and Lord Evans of Rainow
Lord Evans of Rainow (Con)
The noble Lord raises a very important point. I will certainly ensure that the department hears it, and I will feed back to him.
Lord Lansley (Con)
My noble friend will recall that the Medicines and Healthcare products Regulatory Agency in this country was the leading regulatory agency for the approval of new medical devices, including 40% of the most significant such medical devices. What benefits for the authorisation of medical devices might stem from the announcement in the Budget last week of additional resources for the Medicines and Healthcare products Regulatory Agency?
Lord Evans of Rainow (Con)
I thank my noble friend for his question. The Government’s medtech strategy, published in February, will support medical device manufacturers by recognising the importance of domestic production to support resilience and identify practical support. The good news that was articulated in the Budget last week can only add to that.